Cannabis Sativa Inc
OTC:CBDS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its Industry Average (23), the stock would be worth $-0.03 (181% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -28.6 | $0.03 |
0%
|
| Industry Average | 23 | $-0.03 |
-181%
|
| Country Average | 23.2 | $-0.03 |
-181%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Cannabis Sativa Inc
OTC:CBDS
|
2.9m USD | -28.6 | -2.6 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
102.9B USD | 19.6 | 58.2 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
70.3B EUR | 12.3 | 13.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
75.1B USD | 0 | 12.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.6B EUR | 16.7 | 23.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23B EUR | 29.6 | 18.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.7B USD | 19.9 | 21.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.3B USD | 21.4 | 24.3 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 10 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
10.9B USD | -48.7 | -26.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 14.9 | 13.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.4 |
| Median | 23.2 |
| 70th Percentile | 35.1 |
| Max | 3 178 983.5 |
Other Multiples
Cannabis Sativa Inc
Glance View
Cannabis Sativa, Inc. operates as a pharmaceutical company. The company is headquartered in Mesquite, Nevada. The company went IPO on 2010-03-01. The firm's brands include PrestoCorp, hi Brands International and Wild Earth Naturals. The firm's PrestoCorp offers an online telemedicine platform providing customer access to knowledgeable physicians to obtain a medical marijuana recommendation. PrestoDoctor uses secure video conferencing technology to provide a safe and confidential forum for the Doctor patient interview. The firm's hi Brands International products include hi Releaf and hi Releaf plus. Its Wild Earth Naturals products include Recover, Release It, Body Garden, Face Garden and Lip Garden. The firm through its subsidiary GK Manufacturing and Packaging, Inc. operates contract manufacturing lines, which includes packaging design, printing, label design, product formulation and bottling.
